Preterm Birth and PROM Testing Market Outlook (2022 to 2032)
The global Preterm Birth and PROM Testing Market was valued at around US$ 1.7 Billion in 2021. With a projected CAGR of 3.2% for the next ten years, the market is likely to reach a valuation of nearly US$ 1.8 Billion by the end of 2032.
Attributes
Details
Preterm Birth and PROM Testing Market Size (2021A)
US $ 1.7 Billion
Estimated Market Value (2022E)
US $1.8 Billion
Forecasted Market Value (2032)
US $ 2.5 Billion
Global Market Growth Rate (2022 to 2032)
3.2% CAGR
North America Growth Rate (2021)
3.1%
United States Growth Rate(2022 to 2032)
3.4% CAGR
Key Companies Profiled
Qiagen N.V.
Cooper Surgical Inc.
Hologic
Abbott
Biosynex
Medixbiochemica
Sera Prognostics
IQ Products
Creative Diagnostics
Nan jing Liming Biological Preparations Co., Ltd.,
Clinical Innovations LLC
Bioserv Diagnostic GmbH
Future Market Insights’ analysis reveals that most of the market revenue is grossed from Ultrasound Testing, which has a forecasted CAGR of 3.1% from 2022 to 2032. The USA is the leading country for demand, with the forecasted market size in 2032 being US $ 777.8 Million.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What is driving the demand for Preterm Birth and PROM Testing?
World Health Organization statistics show that across the globe, around 15 Million preterm births occur annually, and more than one out of every 10 babies are born preterm. Studies have shown that around 12% of births in the USA are preterm. The increased use of fertility treatments to conceive and the higher global maternity age have led to an increase in the number of multiple births.
France’s latest Perinatal Survey puts the country’s Preterm births at 7.5%, with the frequency being preterm being 6.0% for a single birth and 47.5% for a multiple pregnancy delivery. According to data from the CDC, in 2019 17% of infant deaths were due to preterm birth and low birth weight. Infants born before 24 months have only a 50% chance of survival and over 40% of the babies who make it suffer long-term health complications. However, more than 3/4th of preterm babies can be saved with timely and early identification through testing and subsequent medical care.
A study conducted found that 3% of pregnancies have an occurrence of PROM or Premature Rupture of Membranes. At term, PROM is a complication in nearly 8% of pregnancies. PROM is a large cause of preterm births, accounting for almost a third of preterm deliveries. One of the most serious consequences of the term PROM is the chances of intrauterine infection, with the risk increasing with the duration. According to a study, mothers with a PROM duration of over 72 hours showed a much higher risk of placental infection. Their babies, if born preterm due to PROM complications were also at a higher risk for pneumonia and intracranial hemorrhage.
Since as of yet there is no guaranteed way to prevent PROM from occurring, an accurate assessment of thorough testing is essential to the management and care of these pregnancies in order to ensure the well-being of both the mother and the child. PROM also has a high risk of recurrence, between 16% to 32%, so the frequent observation and testing of mothers who display any possible symptoms are encouraged in order to prevent any complications. This, as well as the fact that providers and researchers are working on studying PROM and Preterm births and are working on rapidly developing new technology and tests, which is leading to the growth in demand.
How have new technologies in POC testing are impacting market growth?
Point-of-Care or POC testing, through which a diagnosis can occur at the time and place of patient care has been a growing field for research. This form of testing can increase access to treatment, especially in remote or resource-scarce areas since it does not require one to send samples away to far-off labs and wait for several days for the results.
Low-cost POC diagnostics when supported by effective treatment strategies, will increase testing, can reduce PROM-related complications, and ensure its management even in low-resource countries and regions. Research is attempting to reduce per-test cost and enhance the accuracy of results, which will benefit the market significantly if there is enough development.
Studies find that Urea and Creatinine based PROM testing, measures with a spectrometer and an enzymatic-based essay, respectively show promise for sensitive and specific detection. As per studies a significant amount of pregnant women around the globe do not have access to ultrasounds or other diagnostic tools. Rapid POC tests are a viable solution for untapped markets in less resource-rich areas and regions such as the Middle East and Africa(MEA) and Asia Pacific, where Preterm birth rates are high.
Find your sweet spots for generating winning opportunities in this market.
How are fetal fibronectin tests contributing to the testing market?
The prevalent method for testing preterm birth due to preterm labor is fetal fibronectin tests, in which the presence of fetal fibronectin in vaginal discharge is tested for, in some cases accompanied by a transvaginal ultrasound test. The results of this test, which are either positive or negative, indicate whether labor will occur in the following two weeks. With a negative fFN test indicating less than 1% risk of delivery in the upcoming 2 weeks, the test is widely used because of this high negative predictive value, since if the results are negative, the healthcare provider and the expecting mother, especially women who may have been symptomatic but are not in true labor and can avoid the use of strong medication and further invasive testing unless absolutely necessary.
While the most prevalent fFN tests currently in use are a solid-phase enzyme-linked immunosorbent assay or ELISA, a rapid bedside version of the test, which can take around 30 minutes to show results, unlike the ELISA which requires 4 to 48 hours after being sent to a laboratory, is expected to boost demand for this type of testing.
Regional Insights
North America will continue to be the Nucleus of Global Preterm Birth and PROM testing Demand.
The preterm birth and PROM testing market in North America was held at US$ 591 Million in 2021. By 2032, the market is expected to reach a valuation of US$ 853 Mn, growing at a CAGR of 3.4% from 2022 to 2032.
According to data from the CDC, the provisional number of births in the USA grew by 1% from the previous year, in contrast to the 2% average decline since 2014. Further, even though the 15 to 24 age group saw a decline in birth rates, birth rates rose for later pregnancies in the 25 to 49 age group. Further, the preterm birth rate rose to the highest reported levels since 2007, with a 4% increase in 2021 compared to that in 2020.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Insights
USA Preterm Birth and PROM testing Market Analysis
The USA has a significant proportion of births that have preterm and PROM complications, with 12% being preterm and 3% dealing with PROM-related complications. This is owing to several demographic factors of the American population. However, technological advancements, availability of resources, and an increase in approvals for testing methods mean that the USA is the highest contributor to revenue, having witnessed a 3.1% CAGR from 2017 to 2022 and having a forecasted CAGR of 3.4%, with a US $219.7 Absolute Dollar growth.
United Kingdom Preterm Birth and PROM testing Market Analysis
The preterm birth and PROM testing market in the United Kingdom was held at US$ 76 Million in 2021. The market is expected to reach a valuation of US$ 103 Million by 2032, growing at a CAGR of 2.6% from 2022 to 2032.
Japan Preterm Birth and PROM testing Market Analysis
In Japan, the preterm birth and PROM testing market is projected to gross an absolute dollar opportunity of US$ 28.7 Million during the forecast period. By 2032, the market is expected to reach US$ 98 Million.
South Korea Preterm Birth and PROM testing Market Analysis
The preterm birth and PROM testing market in South Korea was held at US$ 37 Million in 2021. The market is likely to be valued at US$ 54 Million by 2032, growing at a CAGR of 3.5%.
Category-wise Insights
Why do ultrasound tests lead the market for PROM testing?
Once patients are diagnosed with PROM or preterm birth, period assessments are conducted. Studies have found that in the absence of other maternal or fetal factors, routine and frequent ultrasound examinations are an efficient way to manage PROM. The market through this test type witnessed a CAGR of 2.9% between 2017 and 2021 and is forecasted to gain a CAGR of 3.1%. The frequency of the conduction of these tests, their non-invasive nature, and their use combined with other diagnostic tests means that they lead the market for testing.
Competitive Landscape
Preterm Birth and PROM testing providers are focused on increasing the efficiency, accuracy, and affordability of their tests. The key companies operating in the market include Qiagen N.V., Cooper Surgical Inc., Hologic, Abbott, Biosynex, Medixbiochemica, Sera Prognostics, IQ Products, Creative Diagnostics, Nanjing Liming Biological Preparations Co., Ltd., Clinical Innovations, LLC, and Bioserv Diagnostic GmbH.
Some of the recent development in Preterm Birth and PROM testing are as follows:
In September 2020, PregnanTech, an Israeli company announced the development of LIONESSTM, a device that aims to delay preterm birth. The product is a silicone ring that takes a few minutes to place and functions by remaining set in place to prevent dilatation and keep the cervix elongated. This system can help delay Preterm Births. The device is easily removable and disposable and has a self-release mechanism. The device is currently undergoing further clinical trials.
In April 2018, Qiagen received FDA approval for its PartoSure test which assesses patients with preterm labor symptoms to determine possible spontaneous preterm birth risks.
Similarly, recent developments related to companies manufacturing Preterm Birth and PROM testing have been tracked by the team at Future Market Insights, which is available in the full report.
Key Segments Covered in Preterm Birth and PROM testing Survey
Preterm Birth and PROM testing Market by Type:
Biochemical Markers
Pelvic exam
Ultrasound
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin (fFN)
Other Test Types
Preterm Birth and PROM testing Market by Region:
North America Preterm Birth and PROM testing Market
Latin America Preterm Birth and PROM testing Market
Europe Preterm Birth and PROM testing Market
Asia Pacific Preterm Birth and PROM testing Market
Middle East & Africa Preterm Birth and PROM testing Market
Frequently Asked Questions
How much is the global Preterm Birth and PROM testing Market currently worth?
The global Preterm Birth and PROM testing market was valued at US$ 1.7 Billion in 2021.
What is the Preterm Birth and PROM testing market Forecast through 2032?
The Preterm Birth and PROM testing industry is set to witness a growth rate of 3.2% over the forecast period and be valued at US$ 1.8 Billion by 2032.
At what rate did demand for Preterm Birth and PROM testing increase over the past 5 years?
The Preterm Birth and PROM testing market expanded by 3% from 2017 through 2021.
Who are the key players shaping the Preterm Birth and PROM testing Industry?
Qiagen N.V., Abbott, Hologic, Biosynex, and Cooper Surgical Inc. are some of the key players.
Who are the top 5 countries driving the highest sales of Preterm Birth and PROM testing?
The USA, United Kingdom, China, Japan, and South Korea are expected to be the major drivers of sales.
What is the USA market outlook for Preterm Birth and PROM testing?
USA accounts for over 30% of the global preterm birth and PROM testing market.
Table of Content
1. Executive Summary | Preterm Births and PROM Testing Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2022 to 2032
5.3.1. Biochemical Markers
5.3.2. Pelvic exam
5.3.3. Ultrasound
5.3.4. Uterine Monitoring
5.3.5. Nitazine Test
5.3.6. Ferning Test
5.3.7. Pooling
5.3.8. PAMG-1 Immunoassay
5.3.9. IGFBP Test
5.3.10. Fetal Fibronectin (fFN)
5.3.11. Other Test Types
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Test Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
6.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
7.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
7.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
7.2.1. By Country
7.2.1.1. USA
7.2.1.2. Canada
7.2.2. By Test Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Test Type
7.4. Key Takeaways
8. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Test Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Test Type
8.4. Key Takeaways
9. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. United Kingdom
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Test Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of Asia Pacific
10.2.2. By Test Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.4. Key Takeaways
11. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. United Arab Emirates(UAE)
11.2.1.4. Israel
11.2.1.5. Rest of Middle East and Africa(MEA)
11.2.2. By Test Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. USA
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2021
12.1.2.1. By Test Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2021
12.2.2.1. By Test Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2021
12.3.2.1. By Test Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2021
12.4.2.1. By Test Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2021
12.5.2.1. By Test Type
12.6. United Kingdom
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2021
12.6.2.1. By Test Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2021
12.7.2.1. By Test Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2021
12.8.2.1. By Test Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2021
12.9.2.1. By Test Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2021
12.10.2.1. By Test Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2021
12.11.2.1. By Test Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2021
12.12.2.1. By Test Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2021
12.13.2.1. By Test Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2021
12.14.2.1. By Test Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2021
12.15.2.1. By Test Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2021
12.16.2.1. By Test Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2021
12.17.2.1. By Test Type
12.18. United Arab Emirates(UAE)
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2021
12.18.2.1. By Test Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2021
12.19.2.1. By Test Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Test Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Qiagen N.V.
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Cooper Surgical Inc.
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Hologic
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Abbott
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Biosynex
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Medixbiochemica
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Sera Prognostics
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. IQ Products
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Creative Diagnostics
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Nan jing Liming Biological Preparations Co., Ltd.,
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
14.1.11. Clinical Innovations LLC
14.1.11.1. Overview
14.1.11.2. Product Portfolio
14.1.11.3. Profitability by Market Segments
14.1.11.4. Sales Footprint
14.1.11.5. Strategy Overview
14.1.11.5.1. Marketing Strategy
14.1.12. Bioserv Diagnostic GmbH
14.1.12.1. Overview
14.1.12.2. Product Portfolio
14.1.12.3. Profitability by Market Segments
14.1.12.4. Sales Footprint
14.1.12.5. Strategy Overview
14.1.12.5.1. Marketing Strategy
15. Assumptions & Acronyms Used16. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2017 to 2032
Table 3: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 4: North America Market Value (US$ Million) Forecast by Test Type, 2017 to 2032
Table 5: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 6: Latin America Market Value (US$ Million) Forecast by Test Type, 2017 to 2032
Table 7: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 8: Europe Market Value (US$ Million) Forecast by Test Type, 2017 to 2032
Table 9: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 10: Asia Pacific Market Value (US$ Million) Forecast by Test Type, 2017 to 2032
Table 11: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 12: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 3: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 4: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 5: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 6: Global Market Value (US$ Million) Analysis by Test Type, 2017 to 2032
Figure 7: Global Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 8: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 9: Global Market Attractiveness by Test Type, 2022 to 2032
Figure 10: Global Market Attractiveness by Region, 2022 to 2032
Figure 11: North America Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 12: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 13: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 14: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 15: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 16: North America Market Value (US$ Million) Analysis by Test Type, 2017 to 2032
Figure 17: North America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 18: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 19: North America Market Attractiveness by Test Type, 2022 to 2032
Figure 20: North America Market Attractiveness by Country, 2022 to 2032
Figure 21: Latin America Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 22: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 23: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 24: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 25: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 26: Latin America Market Value (US$ Million) Analysis by Test Type, 2017 to 2032
Figure 27: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 28: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 29: Latin America Market Attractiveness by Test Type, 2022 to 2032
Figure 30: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 31: Europe Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 32: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 33: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 34: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 35: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 36: Europe Market Value (US$ Million) Analysis by Test Type, 2017 to 2032
Figure 37: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 38: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 39: Europe Market Attractiveness by Test Type, 2022 to 2032
Figure 40: Europe Market Attractiveness by Country, 2022 to 2032
Figure 41: Asia Pacific Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 42: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 43: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 44: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 45: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 46: Asia Pacific Market Value (US$ Million) Analysis by Test Type, 2017 to 2032
Figure 47: Asia Pacific Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 48: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 49: Asia Pacific Market Attractiveness by Test Type, 2022 to 2032
Figure 50: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 51: Middle East and Africa Market Value (US$ Million) by Test Type, 2022 to 2032
Figure 52: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032
Figure 53: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 54: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 55: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 56: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2017 to 2032
Figure 57: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032
Figure 58: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032
Figure 59: Middle East and Africa Market Attractiveness by Test Type, 2022 to 2032
Figure 60: Middle East and Africa Market Attractiveness by Country, 2022 to 2032
